LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling

British Journal of Cancer

Volumn 104, Issue 2, 2011, Pages 376-386

  Matsuda, R ^a   Enokida, H ^a   Chiyomaru, T ^a   Kikkawa, N ^b   Sugimoto, T ^b   Kawakami, K ^a   Tatarano, S ^a   Yoshino, H ^a   Toki, K ^a   Uchida, Y ^a   Kawahara, K ^c   Nishiyama, K ^a   Seki, N ^b   Nakagawa, M ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c Kawahara Nephro urology Clinic   (Japan)

Author keywords

8q24.3; array CGH; bladder cancer; LY6K

Indexed keywords

CANCER TESTIS ANTIGEN; LY6K ANTIGEN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; BLADDER EPITHELIUM; CANCER INVASION; CELL GROWTH; CELL MIGRATION; CELL VIABILITY; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 16P; CHROMOSOME 20Q; CHROMOSOME 6P; CHROMOSOME 8Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WOUND HEALING;

ANTIGENS, LY; CHROMOSOME MAPPING; GENE KNOCKDOWN TECHNIQUES; GENOME, HUMAN; GPI-LINKED PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; URINARY BLADDER NEOPLASMS;

EID: 78751569524     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605990     Document Type: Article

References (39)

1. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM (2005) Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11: 7012-7022
2. Canta A, Chiorazzi A, Cavaletti G (2009) Tublin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system. Curr Med Chem 16: 1315-1324
3. Chen JS, Lin SY, Tso WL, Yeh GC, Lee WS, Tseng H, Chen LC, Ho YS (2006) Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis. Mol Carcinog 45: 461-478
4. Choi SH, Kong HK, Park SY, Park JH (2009) Metastatic effect of LY-6K gene in breast cancer cells. Int J Oncol 35: 601-607
5. De Nooij-Van Dalen AG, Van Dongen GA, Smeets SJ, Nieuwenhuis EJ, Stigter-van Walsum M, SnoHw GB, Brakenhoff RH (2003) Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma. Int J Cancer 103: 768-774
6. De Smith AJ, Tsalenko A, Sampas N, Scheffer A, Yamada NA, Tsang P, Ben-Dor A, Yakhini Z, Ellis RJ, Bruhn L, Laderman S, Froguel P, Blakemore AL (2007) Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases. Hum Mol Genet 16: 2783-2794
7. Dyrskjot L, Thykjaer T, Kruhoffer M, Jensen JL, Marcussen N, Hamilton-Dutoit S, Wolf H, Orntoft TF (2003) Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 33: 90-96
8. Gommans WM, Haisma HJ, Rots MG (2005) Engineering zinc finger protein transcription factors: the therapeutic relevance of switching endogenous gene expression on or off at command. J Mol Biol 354: 507-519
9. Gou S, Liu T, Wang C, Yin T, Li K, Yang M, Zhou J (2007) Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties. Pancreas 34: 429-435
10. Heidenblad M, Lindgren D, Veltman JA, Jonson T, Mahlamäki EH, Gorunova L, Van Kessel AG, Schoenmakers EF, Höglund M (2005) Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications. Oncogene 24: 1794-1801
11. Hovey RM, Chu L, Balazs M, DeVries S, Moore D, Sauter G, Carroll PR, Waldman FM (1998) Genetic alterations in primary bladder cancers and their metastases. Cancer Res 58: 3555-3560
12. Hurst CD, Tomlinson DC, Williams SV, Platt FM, Knowles MA (2008) Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification. Oncogene 27: 2716-2727
13. Huszar D, Theoclitou ME, Skolnik J, Herbst R (2009) Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev 28: 197-208
14. Imao T, Koshida K, Endo Y, Uchibayashi T, Sasaki T, Namiki M (1999) Dominant role of E-cadherin in the progression of bladder cancer. J Urol 161: 692-698
15. Inazawa J, Inoue J, Imoto I (2004) Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 95: 559-563
16. Ishikawa N, Takano A, Yasui W, Inai K, Nishimura H, Ito H, Miyagi Y, Nakayama H, Fujita M, Hosokawa M, Tsuchiya E, Kohno N, Nakamura Y, Daigo Y (2007) Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. Cancer Res 67: 11601-11611
17. Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, Coe BP, Snijders A, Albertson DG, Pinkel D, Marra MA, Ling V, MacAulay C, Lam WL (2004) A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36: 299-303
18. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249
19. Kawakami K, Enokida H, Tachiwada T, Gotanda T, Tsuneyoshi K, Kubo H, Nishiyama K, Takiguchi M, Nakagawa M, Seki N (2006) Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep 16: 521-531
20. Kawakami K, Enokida H, Tachiwada T, Nishiyama K, Seki N, Nakagawa M (2007) Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma. J Urol 178: 301-307
21. Kono K, Mizukami Y, Daigo Y, Takano A, Masuda K, Yoshida K, Tsunoda T, Kawaguchi Y, Nakamura Y, Fujii H (2009) Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer. Cancer Sci 100: 1502-1509
22. Lee JW, Lee YS, Yoo KH, Lee KH, Park K, Ahn T, Ko C, Park JH (2006) LY-6K gene: a novel molecular marker for human breast cancer. Oncol Rep 16: 1211-1214
23. Luke C, Tracey E, Stapleton A, Roder D (2009) Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control. Intern Med J 40: 357-362
24. Mahdy E, Pan Y, Wang N, Malmström PU, Ekman P, Bergerheim U (2001) Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade. Anticancer Res 21: 3167-3173
25. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL, Brown PO (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 99: 12963-12968
26. Qiu D, Katanoda K, Marugame T, Sobue T (2009) A joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004). Int J Cancer 124: 443-448
27. Reichling T, Goss KH, Carson DJ, Holdcraft RW, Ley-Ebert C, Witte D, Aronow BJ, Groden J (2005) Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. Cancer Res 65: 166-176
28. Saramäki OR, Porkka KP, Vessella RL, Visakorpi T (2006) Genetic aberrations in prostate cancer by microarray analysis. Int J Cancer 119: 1322-1329
29. Scanlan MJ, Simpson AJ, Old LJ (2004) The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4: 1
30. Shinoda Y, Kozaki K, Imoto I, Obara W, Tsuda H, Mizutani Y, Shuin T, Fujioka T, Miki T, Inazawa J (2007) Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells. Cancer Sci 98: 1078-1086
31. Simon R, Burger H, Semjonow A, Hertle L, Terpe HJ, Bocker W (2000) Patterns of chromosomal imbalances in muscle invasive bladder cancer. Int J Oncol 17: 1025-1029
32. Sobin LH, Wittekind C (2002) TNM Classification of Malignant Tumours, 6th edn. International Union Against Cancer (UICC). Wiley-Liss: New York. pp 199-202
33. Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, Simon R, Schmitt R, Zaak D, Hofstaedter F, Rosenthal A, Baylin SB, Pilarsky C, Hartmann A (2004) Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest 84: 465-478
34. Sugimoto T, Seki N, Shimizu S, Kikkawa N, Tsukada J, Shimada H, Sasaki K, Hanazawa T, Okamoto Y, Hata A (2009) The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma. Genes Chromosomes Cancer 48: 132-142
35. Takemoto M, Shirahama T, Miyauchi T, Matsusako T, Kaneda N, Muramatsu H, Ozawa M, Ohi Y, Muramatsu T (1997) Metanestin, a glycoprotein with metastasis-associated expression in transitional cell carcinoma of the urinary bladder. Int J Cancer 74: 7-14
36. Von Knobloch R, Bugert P, Jauch A, Kälble T, Kovacs G (2000) Allelic changes at multiple regions of chromosome 5 are associated with progression of urinary bladder cancer. J Pathol 190: 163-168
37. Yamamoto Y, Chochi Y, Matsuyama H, Eguchi S, Kawauchi S, Furuya T, Oga A, Kang JJ, Naito K, Sasaki K (2007) Gain of 5p15.33 is associated with progression of bladder cancer. Oncology 72: 132-138
38. Zaharieva BM, Simon R, Diener PA, Ackermann D, Maurer R, Alund G, Knönagel H, Rist M, Wilber K, Hering F, Schönenberger A, Flury R, Jäger P, Fehr JL, Mihatsch MJ, Gasser T, Sauter G, Toncheva DI (2003) High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol 201: 603-608
39. Zhao J, Richter J, Wagner U, Roth B, Schraml P, Zellweger T, Ackermann D, Schmid U, Moch H, Mihatsch MJ, Gasser TC, Sauter G (1999) Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res 59: 5687-5691